nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—KCND2—midbrain—Gilles de la Tourette syndrome	0.0386	0.0831	CbGeAlD
Disopyramide—KCND3—midbrain—Gilles de la Tourette syndrome	0.0337	0.0724	CbGeAlD
Disopyramide—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0326	0.0609	CbGpPWpGaD
Disopyramide—KCND2—nervous system—Gilles de la Tourette syndrome	0.0318	0.0683	CbGeAlD
Disopyramide—KCND2—central nervous system—Gilles de la Tourette syndrome	0.0306	0.0658	CbGeAlD
Disopyramide—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0303	0.0567	CbGpPWpGaD
Disopyramide—KCND3—nervous system—Gilles de la Tourette syndrome	0.0277	0.0595	CbGeAlD
Disopyramide—KCND3—central nervous system—Gilles de la Tourette syndrome	0.0267	0.0573	CbGeAlD
Disopyramide—KCND2—brain—Gilles de la Tourette syndrome	0.0243	0.0522	CbGeAlD
Disopyramide—KCND3—brain—Gilles de la Tourette syndrome	0.0212	0.0455	CbGeAlD
Disopyramide—SCN5A—nervous system—Gilles de la Tourette syndrome	0.0166	0.0357	CbGeAlD
Disopyramide—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0163	0.0305	CbGpPWpGaD
Disopyramide—SCN5A—central nervous system—Gilles de la Tourette syndrome	0.016	0.0344	CbGeAlD
Disopyramide—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0152	0.0284	CbGpPWpGaD
Disopyramide—ORM1—nervous system—Gilles de la Tourette syndrome	0.0152	0.0326	CbGeAlD
Disopyramide—ORM1—central nervous system—Gilles de la Tourette syndrome	0.0146	0.0314	CbGeAlD
Disopyramide—CHRM2—nervous system—Gilles de la Tourette syndrome	0.0141	0.0304	CbGeAlD
Disopyramide—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.0139	0.0299	CbGeAlD
Disopyramide—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.0136	0.0293	CbGeAlD
Disopyramide—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.0134	0.0288	CbGeAlD
Disopyramide—CHRM1—nervous system—Gilles de la Tourette syndrome	0.0129	0.0277	CbGeAlD
Disopyramide—SCN5A—brain—Gilles de la Tourette syndrome	0.0127	0.0273	CbGeAlD
Disopyramide—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.0124	0.0267	CbGeAlD
Disopyramide—KCND2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.0116	0.0217	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0115	0.0216	CbGpPWpGaD
Disopyramide—CHRM3—nervous system—Gilles de la Tourette syndrome	0.0115	0.0248	CbGeAlD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0115	0.0215	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0114	0.0213	CbGpPWpGaD
Disopyramide—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0113	0.0211	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.0113	0.0211	CbGpPWpGaD
Disopyramide—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.0111	0.0239	CbGeAlD
Disopyramide—CHRM2—brain—Gilles de la Tourette syndrome	0.0108	0.0233	CbGeAlD
Disopyramide—SLC22A1—brain—Gilles de la Tourette syndrome	0.0106	0.0228	CbGeAlD
Disopyramide—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0105	0.0197	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0105	0.0196	CbGpPWpGaD
Disopyramide—CHRM1—brain—Gilles de la Tourette syndrome	0.00984	0.0212	CbGeAlD
Disopyramide—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00984	0.0184	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0098	0.0183	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00971	0.0181	CbGpPWpGaD
Disopyramide—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00955	0.0178	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00952	0.0178	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00943	0.0176	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00923	0.0172	CbGpPWpGaD
Disopyramide—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00889	0.0166	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00887	0.0166	CbGpPWpGaD
Disopyramide—CHRM3—brain—Gilles de la Tourette syndrome	0.00881	0.0189	CbGeAlD
Disopyramide—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00878	0.0164	CbGpPWpGaD
Disopyramide—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00827	0.0155	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00824	0.0154	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00822	0.0154	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00816	0.0153	CbGpPWpGaD
Disopyramide—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00803	0.015	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.008	0.015	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00792	0.0148	CbGpPWpGaD
Disopyramide—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00748	0.014	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00745	0.0139	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00738	0.0138	CbGpPWpGaD
Disopyramide—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00633	0.0136	CbGeAlD
Disopyramide—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00623	0.0116	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00621	0.0116	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00615	0.0115	CbGpPWpGaD
Disopyramide—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0061	0.0131	CbGeAlD
Disopyramide—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00524	0.00979	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00522	0.00976	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00517	0.00966	CbGpPWpGaD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00442	0.00827	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00435	0.00814	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00431	0.00806	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00423	0.0079	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00419	0.00782	CbGpPWpGaD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00412	0.00771	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00344	0.00643	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00276	0.00516	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00273	0.00511	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00248	0.00463	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00232	0.00433	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00231	0.00432	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00225	0.0042	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0021	0.00392	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00202	0.00377	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00201	0.00376	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00196	0.00366	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0019	0.00355	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0019	0.00355	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00189	0.00354	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00187	0.0035	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00187	0.0035	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00184	0.00344	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00184	0.00343	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00183	0.00341	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00182	0.0034	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00177	0.00332	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00177	0.00331	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00172	0.00321	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00171	0.0032	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MET—Gilles de la Tourette syndrome	0.00171	0.00319	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00169	0.00317	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00163	0.00304	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00162	0.00303	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00161	0.003	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00158	0.00295	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00157	0.00294	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00156	0.00291	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00291	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00155	0.0029	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00147	0.00275	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00147	0.00274	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00145	0.00271	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00139	0.0026	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00139	0.00259	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00137	0.00257	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00128	0.00239	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00124	0.00231	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00123	0.00231	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00122	0.00228	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.00122	0.00228	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0012	0.00225	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0012	0.00225	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0012	0.00224	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0012	0.00224	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00222	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00119	0.00222	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00118	0.00221	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00112	0.00209	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00112	0.00209	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00111	0.00207	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00103	0.00193	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00103	0.00192	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00102	0.00191	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00102	0.0019	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000952	0.00178	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000784	0.00147	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000782	0.00146	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000774	0.00145	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0007	0.00131	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000698	0.0013	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000691	0.00129	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000679	0.00127	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000677	0.00127	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000671	0.00125	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000635	0.00119	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000633	0.00118	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000633	0.00118	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000631	0.00118	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000627	0.00117	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000625	0.00117	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000617	0.00115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000615	0.00115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000609	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000575	0.00107	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000573	0.00107	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000567	0.00106	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000463	0.000865	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000443	0.000828	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000442	0.000826	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000438	0.000818	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000403	0.000752	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000401	0.00075	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000397	0.000743	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000375	0.000702	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000374	0.000699	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000371	0.000693	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000364	0.000681	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000363	0.000679	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00036	0.000672	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00034	0.000635	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000338	0.000632	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000335	0.000626	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000238	0.000444	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000237	0.000443	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000235	0.000439	CbGpPWpGaD
